UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of biosimilars in oncology

The lancet oncology, 2016-11, Vol.17 (11), p.e502-e509

2016

Volltextzugriff (PDF)

G Protein-Gated Potassium Channels: A Link to Drug Addiction

Trends in pharmacological sciences (Regular ed.), 2017-04, Vol.38 (4), p.378-392

2017

Volltextzugriff (PDF)

Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites

Journal of psychiatric research, 2021-05, Vol.137, p.667-672

2021

Volltextzugriff (PDF)

A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices

Supportive care in cancer, 2022-10, Vol.30 (10), p.7913-7922

2022

Volltextzugriff (PDF)

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Annals of hematology, 2018-12, Vol.97 (12), p.2425-2436

2018

Volltextzugriff (PDF)

Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry

Practical Radiation Oncology, 2024-03, Vol.14 (2), p.e141-e149

2024

Volltextzugriff (PDF)

Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry

Clinical therapeutics, 2018-07, Vol.40 (7), p.1193-1202.e1

2018

Volltextzugriff (PDF)

Real-world efficacy of deep TMS for obsessive-compulsive disorder: interim post-marketing analysis of 192 patients from twenty-two sites

Brain stimulation, 2020-11, Vol.13 (6), p.1847-1847

2020

Volltextzugriff (PDF)

An alternative isovelocity surface model for quantitation of effective regurgitant orifice area in mitral regurgitation with an elongated orifice application to functional mitral regurgitation

JACC. Cardiovascular imaging, 2010-11, Vol.3 (11), p.1091-1103

2010

Volltextzugriff (PDF)

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

The Lancet (British edition), 2000-03, Vol.355 (9208), p.999-1003

2000

Volltextzugriff (PDF)

Quantitative Estimation of Left Ventricular Ejection Fraction from Mitral Valve E-Point to Septal Separation and Comparison to Magnetic Resonance Imaging

The American journal of cardiology, 2006, Vol.97 (1), p.137-140

2006

Volltextzugriff (PDF)

An Alternative Isovelocity Surface Model for Quantitation of Effective Regurgitant Orifice Area in Mitral Regurgitation With an Elongated Orifice

JACC. Cardiovascular imaging, 2010-11, Vol.3 (11), p.1091-1103

2010

Volltextzugriff (PDF)

Noninvasive evaluation of pericardial effusion composition by computed tomography

The American heart journal, 2005-06, Vol.149 (6), p.1120-1127

2005

Volltextzugriff (PDF)

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3921-3929

2015

Volltextzugriff (PDF)

Real-world utilization and costs with biosimilar and reference filgrastim in patients with breast cancer receiving myelosuppressive chemotherapy in a community oncology setting from 2015 to 2017

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.57-57

2021

Volltextzugriff (PDF)

Autologous Transplantation for Aggressive Non-Hodgkin’s Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease

Journal of clinical oncology, 2002-05, Vol.20 (9), p.2344-2352

2002

Volltextzugriff (PDF)

Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study

Clinical therapeutics, 2019-05, Vol.41 (5), p.866-881.e7

2019

Volltextzugriff (PDF)

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

Nature genetics, 2024-09, Vol.56 (9), p.1878-1889

2024

Volltextzugriff (PDF)

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Supportive care in cancer, 2022-07, Vol.30 (7), p.6135-6144

2022

Volltextzugriff (PDF)

Daratumumab (DARA) maintenance therapy following DARA + cyclophosphamide, bortezomib, and dexamethasone (CyBorD) induction therapy in multiple myeloma (MM): End-of-study analysis of LYRA

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8035-8035

2021

Volltextzugriff (PDF)

Characteristics of long-surviving patients with multiple myeloma: Over 12 years of follow-up in the Connect MM Registry

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8027-8027

2022

Volltextzugriff (PDF)

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Clinical therapeutics, 2019-03, Vol.41 (3), p.477-493.e7

2019

Volltextzugriff (PDF)

Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis

BMC neurology, 2013-08, Vol.13 (1), p.104-104, Article 104

2013

Volltextzugriff (PDF)

A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis

NeuroRehabilitation (Reading, Mass.), 2010-01, Vol.27 (2), p.121-128

2010

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of biosimilars in oncology

G Protein-Gated Potassium Channels: A Link to Drug Addiction

Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites

A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US

Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry

Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry

Real-world efficacy of deep TMS for obsessive-compulsive disorder: interim post-marketing analysis of 192 patients from twenty-two sites

An alternative isovelocity surface model for quantitation of effective regurgitant orifice area in mitral regurgitation with an elongated orifice application to functional mitral regurgitation

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

Quantitative Estimation of Left Ventricular Ejection Fraction from Mitral Valve E-Point to Septal Separation and Comparison to Magnetic Resonance Imaging

An Alternative Isovelocity Surface Model for Quantitation of Effective Regurgitant Orifice Area in Mitral Regurgitation With an Elongated Orifice

Noninvasive evaluation of pericardial effusion composition by computed tomography

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens

Real-world utilization and costs with biosimilar and reference filgrastim in patients with breast cancer receiving myelosuppressive chemotherapy in a community oncology setting from 2015 to 2017

Autologous Transplantation for Aggressive Non-Hodgkin’s Lymphoma: Results of a Randomized Trial Evaluating Graft Source and Minimal Residual Disease

Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

Daratumumab (DARA) maintenance therapy following DARA + cyclophosphamide, bortezomib, and dexamethasone (CyBorD) induction therapy in multiple myeloma (MM): End-of-study analysis of LYRA

Characteristics of long-surviving patients with multiple myeloma: Over 12 years of follow-up in the Connect MM Registry

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis

A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis

Aktive Filter

Suchergebnisse filtern